Skip to main content
OpenTrials
Completed

NCT Number: NCT07564817

A Study to Evaluate the Effects of the Speed Sleep Supplement on Sleep Quality and Quantity

This study evaluates the effects of the Speed Sleep supplement on sleep quality and quantity in adults aged 18-65 years. Participants will be randomized to receive either the supplement or placebo for 4 weeks, with outcomes assessed using Fitbit sleep tracking data and questionnaires.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sleep Disturbance Dyssomnias Mental Disorders Nervous System Diseases Parasomnias Sleep Disorders, Intrinsic Sleep Initiation and Maintenance Disorders Sleep Wake Disorders

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Citruslabs

Las Vegas, Nevada, 89118, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female
  • Aged 18-65
  • Experiencing issues with sleep (falling asleep, staying asleep)
  • Generally healthy
  • Willing to discontinue sleep-related supplements
  • Maintain consistent sleep patterns
  • Resides in the United States

Exclusion criteria

  • Chronic medical or sleep disorders
  • Use of sleep medications
  • Hormone therapy or anticoagulants
  • Heavy alcohol use
  • Night shift workers
  • Pregnancy or breastfeeding
  • Smoking or substance abuse
  • Allergies to ingredients

Treatment and study plan

Dietary Supplement: Speed Sleep

Dietary Supplement

Six capsules taken once daily 30 minutes before bedtime.

Placebo

Dietary Supplement

Six rice flour capsules taken once daily 30 minutes before bedtime.

Primary outcomes

  1. Change in Sleep Score

    Time frame: Baseline and Week 4

    Assessed using Fitbit-generated sleep score reflecting overall sleep quality. Higher scores indicate better sleep quality.

  2. Change in Total Sleep Time

    Time frame: Baseline and Week 4

    Measured using Fitbit as total time asleep during the night.

  3. Change in Time Awake During Sleep Period

    Time frame: Baseline and Week 4

    Measured using Fitbit as total time awake during the sleep period.

  4. Change in Number of Awakenings

    Time frame: Baseline and Week 4

    Measured using Fitbit as number of awakenings during the sleep period.

  5. Change in Deep Sleep Duration

    Time frame: Baseline and Week 4

    Measured using Fitbit as time spent in deep sleep stages.

  6. Change in REM Sleep Duration

    Time frame: Baseline and Week 4

    Measured using Fitbit as time spent in REM sleep stages.

  7. Change in Sleep Quality Score (SQS)

    Time frame: Baseline, Week 1, Week 2, Week 3, Week 4

    Assessed using the validated Sleep Quality Score (SQS) questionnaire. Scores reflect subjective sleep quality, with changes over time indicating improvement or decline.

Secondary outcomes

  1. Change in Sleep Latency

    Time frame: Baseline, Week 1, Week 2, Week 3, Week 4

    Assessed via questionnaire responses evaluating time required to fall asleep.

  2. Change in Self-Reported Anxiety Levels

    Time frame: Baseline, Week 1, Week 2, Week 3, Week 4

    Assessed via questionnaire responses evaluating perceived anxiety related to sleep.

  3. Change in Self-Reported Level of Relaxation

    Time frame: Baseline, Week 1, Week 2, Week 3, Week 4

    Assessed via questionnaire responses evaluating perceived relaxation before sleep.

Sponsors and collaborators

Lead sponsor

Bio Nature Health

Industry

Collaborators

  • Citruslabs

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
May 4, 2026
Registry last updated
May 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.